BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Tools, data and AI companies at BIO‑Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
39 tools, data and AI companies are at BIO-Europe 2026 — 36 presentations on the program. Most represented: Sartorius (2 on the program), Evaluate (1 on the program), Deep Intelligent Pharma (1 on the program). 33 of them have their own page in this guide. As of Nov 10, 2026.
Track
Top represented
Showing 1–19 of 39 organizations
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Sartorius Göttingen, Germany | |
Supplies bioprocess equipment, consumables and laboratory instruments for biopharmaceutical development and manufacturing. | Panel Mon Nov 9 14:00–14:45 Community Conversations – Session 1 Attendees join small-group lunch tables on a topic of their choice, from regulatory strategy and global launches to hiring talent and managing partnerships. Business of BiotechRegulatory Strategy Panel Mon Nov 9 15:00–15:45 Community Conversations – Session 2 A second round of the same small-group lunch tables, letting attendees switch to another topic such as regulatory strategy, launches or partnerships. Business of BiotechRegulatory Strategy |
Evaluate London, United Kingdom | ◆Platinum Sponsor |
Provides pharmaceutical market intelligence, including sales forecasts, pipeline and deal data. | Panel Mon Nov 9 17:00–17:45 AI in the Lab: Why Greater Efficiency Could Mean More Drugs, Not Fewer Scientists Whether AI can speed drug development, not just discovery, how it is changing clinical trials, and whether it will replace some scientists. Ecosystem InnovationBusiness of Biotech Keynote Mon Nov 9 12:00–13:00 Building a competitive and impactful European biotech community: Perspectives from the European Life Sciences Coalition, Argenx and Tubulis How Europe can keep biotech talent, money and companies at home by drawing in big investors, speeding regulation and building stronger stock markets. Ecosystem InnovationBusiness of Biotech |
◆Platinum Sponsor | |
AI company offering AI-powered clinical development services and software, from protocol design and data management to regulatory documents. | Talk Mon Nov 9 09:00–10:00 Doctor-to-Doctor: A PI-Led Pathway into Japan Using AI, DCT, and Registration-Directed Investigator-Initiated Trials to Reach Japanese Patients Faster How trials led by the right Japanese doctor, rather than a contract research company, can take a drug toward approval in Japan. Clinical StrategyRegulatory Strategy |
◇Silver Sponsor | |
AI platform that gathers scientific evidence and applies diligence frameworks to help pharma, biotech and deal teams evaluate drug assets. | Panel Tue Nov 10 14:00–14:25 Faster, Sharper, More Competitive: How Pharma BD Is Evolving and How Biotechs Can Keep Pace How pharma deal teams now screen incoming biotech offers with new tools, and what a well-prepared biotech pitch looks like today. |
◇Silver Sponsor | |
Clinical trial planning software and data covering patient, country and site feasibility, for pharma and biotech companies and contract research organizations. | Panel Tue Nov 10 15:00–15:25 Expanding Global Clinical Trials: Opportunities and Challenges in Emerging Markets How to expand clinical trials into emerging markets and underserved groups, from picking contract research companies and sites to building local partnerships. |
3DBioFibR Halifax, Canada | |
Makes collagen fibers used in 3D bioprinting, cell culture scaffolds and tissue engineering. | Panel Mon Nov 9 14:00–14:25 Get in the Mix with Canada’s Picks: Innovation in Life Sciences Selected Canadian companies present their health technologies, alongside an overview of Canada's life sciences sector and its partnership opportunities. |
A-Alpha Bio Seattle, WA | |
Measures protein–protein interactions at large scale and uses the data with machine learning to help engineer protein medicines. | Talk Tue Nov 10 14:15–14:30 Antibodies: A-Alpha Bio Lab and AI tools that measure and predict how strongly millions of protein pairs bind, used to design biologics and molecular glues. |
AB Cube Paris, France | |
Software group making clinical trial data management software and SafetyEasy, a cloud system for processing and reporting drug-safety cases. | Talk Tue Nov 10 15:30–15:45 Technologies and Tools: AB Cube Software that links clinical trial data capture with drug-safety reporting, so adverse events in a trial flow straight into safety case files. |
Offers an AI platform that analyses omics data for researchers without any coding. | Talk Wed Nov 11 09:40–09:50 Drug Discovery and Development: aimed analytics GmbH Software that lets research teams ask plain-language questions of large biological datasets and get reusable AI-built analyses without coding. |
AinB Gwacheon, South Korea | |
Korean company using AI to design and optimise antibodies and to improve how antibodies are produced. | Talk Tue Nov 10 14:30–14:45 Antibodies: AinB A Seoul company whose AI designs lab-tested antibody drug candidates in 28 days and retrains on every new experiment. |
AlphaSense New York, New York | |
Market intelligence platform using AI search across company filings, broker research, expert call transcripts and news. | Panel Mon Nov 9 13:00–13:45 The therapeutic landscape backed by analyst insights Which disease areas analysts rate most promising for new drugs and investment, and how new science and rule changes are reshaping them. |
Uses machine learning to engineer proteins, raising production yield and quality for research tools and therapeutics. | Talk Tue Nov 10 13:00–13:15 Technologies and Tools: Avenue Biosciences Protein engineering and machine learning, trained on a large lab dataset, to improve how mammalian cells produce and secrete therapeutic proteins. |
Builds physics-informed AI models that predict how strongly drug molecules bind their targets, and their other chemical properties. | Talk Tue Nov 10 14:45–15:00 Technologies and Tools: Azulene Labs A company whose physics-based AI models predict how tightly drug molecules bind their targets, even for unusual chemistry with little lab data. |
Information and analytics company providing life sciences and healthcare data, market research and intellectual property services. | Panel Tue Nov 10 14:30–14:55 The Next Generation of European Entrepreneurs: From Scientific Innovation to Life Sciences Impact What makes a successful life sciences founder, and how founders in Europe can turn discoveries into biotech companies that compete worldwide. |
Concr Cambridge, United Kingdom | |
Software company modelling biological risk in cancer drug development. | Talk Wed Nov 11 10:30–10:40 Biomarkers/Diagnostics/Imaging: Concr AI borrowed from astrophysics that builds virtual copies of cancer patients from sparse data to guide biomarker work and simulate clinical trials. |
Makes single-molecule analysis devices that read antibody quality, such as titer, glycosylation and aggregation, from the first days of cell line development. | Talk Tue Nov 10 14:00–14:15 Technologies and Tools: Constellate Proteomics Devices that read antibody drug samples one molecule at a time, measuring yield, sugar groups, clumping and charge from the start of development. |
Swiss company whose FluidFM technology works on single living cells at nanoscale precision, for cell analysis and genome editing. | Talk Tue Nov 10 17:00–17:15 Drug Discovery and Development: Cytosurge AG A Swiss company that reads a living cell's active genes without killing it, so one cell can be compared before and after a change. |
Software company building digital-twin simulations of clinical trials to test drug development decisions before running them. | Panel Tue Nov 10 13:00–13:55 Unlocking APACs Clinical Trials Potential: Navigating Regulatory Pathways, Bridging Strategies and Market Access Across the Region How to run clinical trials and win approval in Japan, Korea, Taiwan and Southeast Asia, and when studies in local patients pay off. |
AI drug discovery company offering first-in-class discovery, allosteric and dual-target drug design, and its BioTrajectory AI platform. | Talk Tue Nov 10 16:00–16:15 Autoimmune/Inflammation: Divamics Inc. Drug discovery that combines AI with molecular dynamics simulations of how molecules move, to find new lead compounds faster. |
Find buyers from tools, data and AI companies
Tell us what you sell and we’ll find the people at these tools, data and AI companies most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse BIO-Europe 2026 by
Organization type
Track
Everyone
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction